
By Townhall Chicago News Staff
The American Medical Association and the Federation of State Medical Boards on Wednesday released a joint report outlining accountability standards for artificial intelligence used in medical settings, raising urgent questions about who bears responsibility when AI tools influence patient care.
The report, titled “AI and the Practice of Medicine: Examining Accountability and Responsibility in the AI Era,” synthesizes findings from a stakeholder forum held Sept. 14 in Washington, D.C., that brought together more than 200 physicians, medical board representatives, patients, policymakers and technology developers.
“State medical boards exist to protect patients, and that mission does not change as the tools of medicine change,” FSMB President and CEO Humayun J. Chaudhry said in a news release. “As AI begins to perform an increasing number of clinical functions once reserved for licensed physicians, patients deserve clarity about who is responsible for their care and who is accountable when something goes wrong.”
Chaudhry said the forum “brought forward candid and sometimes divergent perspectives” and “made clear that innovation and accountability must advance together.”
The proceedings addressed a central question: As AI increasingly performs functions historically reserved for licensed physicians, how should physician responsibility and state medical board oversight evolve? Discussion focused on autonomous and semiautonomous AI tools and their implications for clinical responsibility, regulatory approaches and the physician-patient relationship.
The report found that existing regulatory, licensure and liability frameworks were not designed for AI and need to be modernized. It also noted that patients and medical professionals are adopting AI faster than the health system is adapting.
“Patients and physicians are embracing AI at a remarkable pace, and the questions it raises about responsibility cannot wait,” AMA CEO and Executive Vice President John Whyte said in the release. “But there is a difference between automating medical tasks and automating medicine itself.”
Whyte said physicians “must help define where that line is drawn so that human judgment, trust and the physician-patient relationship remain at the center of care.”
The report identified five priority areas for future work: establishing best practices for AI use in clinical care; clarifying the boundary between clinical technology and the practice of medicine; modernizing oversight, accountability and liability frameworks; preparing the physician and care team workforce through updated education and training; and preserving patient-centered care and trust.
The AMA, headquartered in Chicago, said its Center for Digital Health and AI is advancing AI governance, economic sustainability and care transformation so physicians take a leading role in shaping how AI is developed and used in medicine.
The FSMB’s workgroup on the regulation of AI in medical practice plans to release draft guidance and recommendations for public comment in December, ahead of a formal vote on adoption by the FSMB House of Delegates in April 2027, according to the release.
The forum convened representatives of state medical boards, specialty societies, health systems, technology developers, regulators, legal experts and academics, as well as patients and patient advocates.
The full proceedings report is available on the AMA’s website. The report was developed with support from Manatt Health, which organized and facilitated the September forum.